Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CURB-2: XR-NTX + XR-BUP for Cocaine Use Disorder
NCT05262270Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone, buprenorphine extended-release injection in cocaine use disorder (CUD), sponsored by UT Southwestern Medical Center. Started Apr 2023; status: completed.
02
Drugs
naltrexonebuprenorphine extended-release injection
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT05262270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05262270.